Combinations, Sequencing, and the Contribution of Components: New Frontline Standards for Metastatic Urothelial Carcinoma
J Clin Oncol
.
2023 Sep 1;41(25):4084-4086.
doi: 10.1200/JCO.23.00987.
Epub 2023 Jul 25.
Authors
Arlene O Siefker-Radtke
1
,
Diana Cauley
2
,
Omar Alhalabi
1
Affiliations
1
The Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
2
The Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX.
PMID:
37490639
DOI:
10.1200/JCO.23.00987
No abstract available
Publication types
Editorial
Comment
MeSH terms
Carcinoma, Transitional Cell* / genetics
Carcinoma, Transitional Cell* / secondary
Humans
Urinary Bladder Neoplasms* / genetics
Urinary Bladder Neoplasms* / pathology
Urinary Bladder Neoplasms* / therapy